On August 30, 2016, a former Progenics Pharmaceuticals Inc chemist who won a $1.66 million last year alleging a biotechnology company of retaliating against him for whistleblower claims was awarded approximately another $3.3 million.
Mr. Perez claimed he was fired in 2008 after alleging that the company defrauded shareholders by falsely claiming a newly tested drug was effective. The full amount of the verdict awarded to Mr. Perez was for compensatory damages. Mr. Perez, had asked U.S. District Judge in Manhattan to order Progenics to reinstate him.
Progenics Pharmaceuticals Inc is a biopharmaceutical company concentrating on research and development for biotechnology product candidates in oncology, virology, supportive care and gastroenterology.